Nestle India
- P/E
- 58.21
Key Fundamentals
LargecapFood ProductsFMCGPrice-based figures as of · EPS basis: Standalone · TTM
- ROCE
- 84.10%
- Debt to Equity
- 0.08
- EPS (TTM)
- ₹21.44
- Book Value
- ₹29.96
- Market Cap
- —
- P/E (TTM)
- 58.21
- P/B
- 41.66
- ROE
- 73.20%
- Dividend Yield
- 1.12%
- EBITDA
- ₹5,346 Cr
- 52W High
- ₹1,553.00
- 52W Low
- ₹1,147.40
- Day Range
- ₹1,228.40 – ₹1,272.80
- Volume
- 24,12,794
Peer Comparison
Fast Moving Consumer Goods › Food Products › Packaged Foods
| ₹1,248.00 | 58.21 | ₹2,42,042 Cr | 41.66 | 1.12% | 73.20% | 84.10% | ₹25,581 Cr | ₹4,134 Cr | |
| ₹4,946.30 | 45.75 | ₹1,19,473 Cr | 23.33 | 1.84% | 53.50% | 56.00% | ₹19,529 Cr | ₹2,610 Cr | |
| ₹488.80 | 82.57 | ₹15,590 Cr | 2.63 | 0.24% | 3.98% | 4.91% | ₹4,537 Cr | ₹188 Cr | |
| ₹472.90 | 43.79 | ₹11,876 Cr | 7.38 | 0.27% | 17.80% | 22.00% | ₹2,872 Cr | ₹272 Cr | |
| ₹1,274.20 | 6.89 | ₹8,824 Cr | 1.26 | 1.36% | 18.70% | 33.00% | ₹19,915 Cr | ₹2,585 Cr | |
| ₹208.16 | 43.01 | ₹6,436 Cr | 5.03 | 0.62% | 11.40% | 14.10% | ₹2,119 Cr | ₹149 Cr | |
| ₹246.88 | 36.68 | ₹3,136 Cr | 5.73 | 0.20% | 4.72% | 11.70% | ₹1,608 Cr | ₹84 Cr | |
| Median 7 companies | ₹488.80 | 43.79 | ₹11,876 Cr | 5.73 | 0.62% | 17.80% | 22.00% | ₹4,537 Cr | ₹272 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 88
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 29
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 73
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 89
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 36
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 49
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
4- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 92.3%
- Company has been maintaining a healthy dividend payout of 74.3%
Weaknesses
2- Stock is trading at 38.5 times its book value
- The company has delivered a poor sales growth of 11.6% over past five years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 8 | 5 | 6 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bearish | 6 | 0 | 4 |
Oscillators
Neutral
Overall
Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 47.33
- Neutral
- MACD (12,26,9)
- −38.63
- Bullish
- SMA (50)
- 1,334.01
- Bearish
- SMA (200)
- 1,359.45
- Bearish
As of
Analyst Rating
20 of 35 analysts rate Buy, 11 Hold, 4 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 10Y | Irregular period |
|---|---|
| 5Y | Irregular period |
| 3Y | Irregular period |
| 1Y | +14.62% |
| TTM | +21.68% |
Net profit
| 10Y | Irregular period |
|---|---|
| 5Y | Irregular period |
| 3Y | Irregular period |
| 1Y | +6.97% |
| TTM | +38.12% |
Operating cash flow
| 10Y | Irregular period |
|---|---|
| 5Y | Irregular period |
| 3Y | Irregular period |
| 1Y | +71.99% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | Irregular period |
|---|---|
| 5Y | Irregular period |
| 3Y | Irregular period |
| 1Y | −0.70 pp |
| TTM | +1.00 pp |
Revenue by year
| Dec 2016 | ₹9,141 Cr |
|---|---|
| Dec 2017 | ₹10,010 Cr |
| Dec 2018 | ₹11,292 Cr |
| Dec 2019 | ₹12,369 Cr |
| Dec 2020 | ₹13,350 Cr |
| Dec 2021 | ₹14,741 Cr |
| Dec 2022 | ₹16,897 Cr |
| Dec 2023 | ₹19,126 Cr |
| Mar 2025 | ₹20,202 Cr |
| Mar 2026 | ₹23,155 Cr |
Net profit by year
| Dec 2016 | ₹1,001 Cr |
|---|---|
| Dec 2017 | ₹1,225 Cr |
| Dec 2018 | ₹1,607 Cr |
| Dec 2019 | ₹1,968 Cr |
| Dec 2020 | ₹2,082 Cr |
| Dec 2021 | ₹2,118 Cr |
| Dec 2022 | ₹2,391 Cr |
| Dec 2023 | ₹2,999 Cr |
| Mar 2025 | ₹3,314 Cr |
| Mar 2026 | ₹3,545 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Nestle India Ltd trades at ₹1,195 as of 2026-11-02 with a market cap of ₹2,27,907 crore. The company commands a PE of 55.74x and a price-to-book of 39.89x, reflecting premium valuations, while delivering a robust ROE of 67.85% and maintaining a near debt-free balance sheet with a debt-to-equity ratio of 0.08.
- Exceptional return on equity of 67.85% as of 2026-11-02, with a 3-year average ROE of 92% and a 5-year average of 98%, indicating highly efficient capital deployment
- Virtually debt-free balance sheet with a debt-to-equity ratio of just 0.08, providing significant financial flexibility and resilience during economic downturns
- TTM sales growth of 22% represents a sharp acceleration compared to the 5-year compounded sales growth of 12% and the 3-year rate of 11%, suggesting improving topline momentum
- TTM profit growth of 35% significantly outpaces the 10-year compounded profit growth of 15% and 3-year rate of 13%, reflecting expanding profitability
- Healthy dividend payout ratio of 74.3% with a current dividend yield of 1.2%, rewarding shareholders with consistent capital returns
- Long-term compounded profit growth of 15% over 10 years demonstrates sustained earnings power through multiple economic cycles
- ROCE of 56.08% underscores the company's ability to generate strong returns on total capital employed, well above the cost of capital for most FMCG firms
- Stock trades at 39.89x book value, an extreme premium that prices in sustained high returns far into the future
- 5-year compounded sales growth of only 12% and 3-year sales growth of 11% indicate a moderate topline trajectory relative to the premium valuation
- Stock price CAGR of -1% over 3 years and -7% over 1 year shows the stock has destroyed value for medium-term holders despite solid fundamentals
- Current price of ₹1,195 sits 23% below the 52-week high of ₹1,553, indicating a sustained downtrend from recent peaks
- 5-year compounded profit growth of 11% lags the 10-year rate of 15%, suggesting a period of slower earnings expansion in the medium term
- 5-year stock CAGR of just 5% implies that much of the earnings growth has been absorbed by valuation compression rather than translating into shareholder returns
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Nestle India delivered strong Q2 FY27 numbers with 20-21% revenue growth and ~37% PAT growth, driven by healthy volumes and margin expansion from lower coffee prices. However, the stock sold off 6.2% post-results as management flagged food inflation concerns, and FSSAI regulatory scrutiny across multiple product lines (Nescafe RTD, infant nutrition, renal nutrition) adds reputational overhang. The underlying business momentum is solid with volume-led growth and premiumisation working, but sustained food inflation and recurring regulatory notices are near-term risks to watch.
- Biggest Nifty50 loser, down 6.2% Oct 20
Nestle India fell 6.2% during the week, the biggest loser among Nifty50 stocks, after Q2 FY27 earnings and CMD acknowledged rising food inflation as a reality.
- FSSAI notices on multiple products Oct 17
FSSAI issued notices to Nestle India for misleading labels on Nescafe Ready-to-Drink beverages (conflicting 'Flavoured Milk' vs 'Dairy Based Drink' classifications) and for selling 'Nestle Resource Renal' without requisite prior approval. This follows separate regulatory action on infant nutrition products in September 2026.
- Food inflation pressuring margins Oct 20
CMD Manish Tiwary acknowledged rising food inflation as a reality, with raw-material cost trends flagged as a key monitorable despite near-term margin expansion from lower coffee prices.
- Q2 revenue up 20-21% YoY Oct 13
Brokerage estimates project Q2 FY27 revenue of ₹6,765-6,809 crore (20-21% YoY growth) and PAT of ₹1,022-1,034 crore (37-38% YoY growth), with volume growth around 10% and real internal growth of ~14%.
- Margin expansion despite inflation Oct 13
EBITDA margins expected to expand 162-170 bps YoY to 23.6-23.7%, with gross margin expanding 79-130 bps aided by lower coffee prices and improved sales mix. EBITDA estimated at ₹1,616 crore, up 28.8% YoY.
- Premiumisation and distribution gains Oct 13
Confectionery and beverages segments expected to perform well, supported by quick commerce penetration and premiumisation trends across Maggi, Nescafe, KitKat, Milkmaid and Cerelac portfolios.
- Senior management reshuffle for 2027 Oct 21
Nestle India appointed Gopichandar Jagatheesan and Mansi Khanna as senior managers effective Jan 1, 2027, while Vineet Singh moves to an affiliate role.
- Nescafe products deemed safe Oct 17
Nestle India maintained that Nescafe RTD beverages are safe to consume and meet all food safety requirements, stating the FSSAI issue relates only to label classification, not product safety or quality.
- Stock trading near 52-week range Oct 13
Shares traded around ₹1,310-1,320 with a market cap of ~₹2.55 lakh crore, within a 52-week range of ₹1,159-1,553.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,037 | 4,600 | 5,268 | 4,814 | 5,104 | 4,780 | 5,504 | 5,096 | 5,644 | 5,667 | 6,748 | 6,378 | 6,788 |
| Expenses | 3,812 | 3,505 | 3,918 | 3,700 | 3,936 | 3,677 | 4,116 | 3,996 | 4,411 | 4,466 | 4,976 | 4,840 | 5,173 |
| Operating Profit | 1,225 | 1,095 | 1,350 | 1,114 | 1,168 | 1,103 | 1,388 | 1,100 | 1,233 | 1,201 | 1,772 | 1,538 | 1,615 |
| OPM % | 24% | 24% | 26% | 23% | 23% | 23% | 25% | 22% | 22% | 21% | 26% | 24% | 24% |
| Other Income | 140 | −77 | 37 | 39 | 298 | 4 | 8.44 | 4 | 6 | 170 | −18 | 16 | 17 |
| Interest | 31 | 23 | 26 | 32 | 32 | 35 | 38 | 47 | 46 | 28 | 37 | 42 | 40 |
| Depreciation | 111 | 109 | 109 | 113 | 122 | 150 | 155 | 157 | 163 | 174 | 205 | 188 | 192 |
| PBT | 1,222 | 886 | 1,251 | 1,009 | 1,312 | 922 | 1,205 | 900 | 1,029 | 1,168 | 1,513 | 1,324 | 1,399 |
| Tax % | 26% | 26% | 25% | 26% | 25% | 25% | 26% | 27% | 27% | 13% | 26% | 26% | 27% |
| Net Profit | 908 | 656 | 934 | 747 | 986 | 696 | 885 | 659 | 753 | 1,018 | 1,114 | 975 | 1,027 |
| EPS (₹) | 4.71 | 3.4 | 4.84 | 3.87 | 5.12 | 3.61 | 4.59 | 3.42 | 3.91 | 5.28 | 5.78 | 5.06 | 5.32 |
Profit & Loss
₹ Cr| Particulars | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Mar 2024 15m | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8,175 | 9,141 | 10,010 | 11,292 | 12,369 | 13,350 | 14,741 | 16,897 | 19,126 | 24,394 | 20,202 | 23,155 | 25,581 |
| Expenses | 6,620 | 7,292 | 7,913 | 8,675 | 9,443 | 10,149 | 11,178 | 13,191 | 14,655 | 18,551 | 15,430 | 17,848 | 19,455 |
| Operating Profit | 1,555 | 1,850 | 2,097 | 2,618 | 2,926 | 3,202 | 3,562 | 3,706 | 4,471 | 5,843 | 4,771 | 5,307 | 6,126 |
| OPM % | 19% | 20% | 21% | 23% | 24% | 24% | 24% | 22% | 23% | 24% | 24% | 23% | 24% |
| Other Income | −391 | 140 | 177 | 259 | 247 | 146 | −112 | 107 | 116 | 159 | 352 | 160 | 185 |
| Interest | 3 | 91 | 92 | 112 | 129 | 164 | 202 | 155 | 119 | 145 | 136 | 158 | 147 |
| Depreciation | 347 | 354 | 342 | 336 | 370 | 370 | 391 | 403 | 429 | 568 | 540 | 699 | 759 |
| PBT | 814 | 1,545 | 1,839 | 2,429 | 2,673 | 2,813 | 2,857 | 3,256 | 4,038 | 5,289 | 4,447 | 4,610 | 5,404 |
| Tax % | 31% | 35% | 33% | 34% | 26% | 26% | 26% | 27% | 26% | 26% | 25% | 23% | — |
| Net Profit | 563 | 1,001 | 1,225 | 1,607 | 1,968 | 2,082 | 2,118 | 2,391 | 2,999 | 3,933 | 3,314 | 3,545 | 4,134 |
| EPS (₹) | 2.92 | 5.19 | 6.35 | 8.33 | 10.21 | 10.8 | 10.99 | 12.4 | 15.55 | 20.4 | 17.19 | 18.38 | 21.44 |
| Div. Payout % | 83% | 61% | 68% | 69% | 168% | 93% | 91% | 89% | 56% | 79% | 79% | 65% | — |
Balance Sheet
₹ Cr| Particulars | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 193 | 193 |
| Reserves | 2,721 | 3,186 | 3,324 | 3,577 | 1,822 | 1,923 | 1,850 | 2,363 | 2,363 | 3,244 | 4,021 | 5,116 | 5,770 |
| Borrowings | 18 | 33 | 35 | 35 | 189 | 147 | 266 | 271 | 271 | 345 | 1,167 | 444 | 464 |
| Other Liabilities | 3,251 | 3,495 | 3,907 | 4,379 | 5,065 | 5,733 | 6,021 | 6,249 | 6,249 | 6,838 | 7,040 | 7,604 | 7,957 |
| Total Liabilities | 6,086 | 6,810 | 7,363 | 8,088 | 7,173 | 7,900 | 8,234 | 8,979 | 8,979 | 10,523 | 12,324 | 13,357 | 14,384 |
| Fixed Assets | 2,898 | 2,730 | 2,616 | 2,401 | 2,341 | 2,179 | 2,995 | 3,044 | 3,044 | 3,460 | 5,474 | 6,290 | 6,326 |
| CWIP | 231 | 188 | 94 | 105 | 143 | 639 | 246 | 358 | 358 | 1,742 | 1,173 | 507 | 553 |
| Investments | 1,325 | 1,756 | 1,979 | 2,658 | 1,751 | 1,464 | 774 | 778 | 778 | 464 | 706 | 706 | 777 |
| Other Assets | 1,633 | 2,136 | 2,673 | 2,924 | 2,937 | 3,618 | 4,219 | 4,799 | 4,799 | 4,857 | 4,972 | 5,854 | 6,728 |
| Total Assets | 6,086 | 6,810 | 7,363 | 8,088 | 7,173 | 7,900 | 8,234 | 8,979 | 8,979 | 10,523 | 12,324 | 13,357 | 14,384 |
Cash Flow
₹ Cr| Particulars | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 1,098 | 1,466 | 1,818 | 2,052 | 2,295 | 2,454 | 2,236 | 2,737 | 3,392 | 4,175 | 2,935 | 5,048 |
| Investing | −70 | −126 | −131 | −52 | 83 | −321 | −1,920 | −392 | −927 | −1,237 | −1,811 | −624 |
| Financing | −498 | −666 | −997 | −1,317 | −3,602 | −1,956 | −2,020 | −2,123 | −2,436 | −3,135 | −1,846 | −3,179 |
| Net Cash Flow | 529 | 674 | 691 | 683 | −1,223 | 177 | −1,704 | 223 | 29 | −198 | −723 | 1,244 |
| Free Cash Flow | 949 | 1,353 | 1,622 | 1,890 | 2,143 | 1,980 | 1,505 | 2,197 | 2,028 | 2,296 | 930 | 4,221 |
| CFO/EBITDA | 93 | 106 | 116 | 112 | 101 | 99 | 83 | 97 | 100 | 94 | 82 | 115 |
Ratios
| Particulars | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 4 | 4 | 3 | 4 | 4 | 5 | 4 | 4 | 4 | 4 | 7 | 5 |
| Inventory Days | 103 | 107 | 91 | 92 | 107 | 107 | 111 | 110 | 83 | 83 | 139 | 105 |
| Days Payable | 94 | 91 | 99 | 118 | 124 | 115 | 122 | 121 | 92 | 112 | 128 | 129 |
| Cash Conversion Cycle | 12 | 20 | −5 | −22 | −14 | −3 | −7 | −7 | −5 | −24 | 18 | −19 |
| Working Capital Days | −21 | −10 | −15 | −21 | −20 | −22 | −20 | −16 | −10 | −19 | −19 | −24 |
| ROCE % | 46% | 54% | 57% | 71% | 96% | 139% | 150% | 138% | 153% | 169% | 96% | 84% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Nestle insights
73 extracted metrics across FY01–FY27.
Documents
- Concall · Aug 2026Transcript PPT Recording
- Concall · Feb 2025Transcript PPT Recording
- Concall · Apr 2024PPT
- Q2 FY24 concall · Oct 2023Transcript PPT
- Concall · Feb 2023Transcript PPT
- 15 Oct 2026
- 22 Jul 2026
- 21 Apr 2026
- 24 Jun 2026
- 27 Mar 2025
- 27 Nov 2024
- 28 Nov 2023
- 30 Nov 2022
- General announcements 15 Oct 2026
- General announcements 6 Oct 2026
Frequently Asked Questions about Nestle India
What does Nestle India Ltd do?
Where is Nestle India Ltd (NESTLEIND) listed?
Which sector does Nestle India Ltd belong to?
What is the PE ratio of Nestle India Ltd?
What is the 52-week high and low of Nestle India Ltd?
Does Nestle India Ltd pay dividends?
What is the Return on Equity (ROE) of Nestle India Ltd?
Company Information
Nestle India Limited is a subsidiary of Nestle which is a Swiss MNC. The company operates in the Food segment.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/NESTLEIND.md for Nestle India Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.